Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Mankind Pharma Shares In Focus As InCred Initiates Coverage, Eyes 11% Upside — Check Target Price

    1 day ago

    InCred has set a target price of Rs 2,821 on Mankind Pharma stock, marking an upside of 11%.
    Click here to Read More
    Previous Article
    Gold Steadies As Traders Look To Fed For Interest-Rate Outlook
    Next Article
    LG Energy Profit Misses Estimates Amid Slow EV Demand

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment